OI
Oakbrook Investments Portfolio holdings
AUM
$39.2M
Turnover
87.07%
1-Year Est. Return
3.66%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$1.51B
AUM Growth
-$24.3M
(-1.6%)
Cap. Flow
-$65.2M
Cap. Flow
% of AUM
-4.32%
Top 10 Holdings %
Top 10 Hldgs %
23.13%
Holding
609
New
85
Increased
120
Reduced
312
Closed
88
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$10.4M |
| 2 |
JPMorgan Chase
JPM
|
+$8M |
| 3 |
Visa
V
|
+$6.68M |
| 4 |
Nike
NKE
|
+$5.67M |
| 5 |
Stericycle Inc
SRCL
|
+$4.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
W.W. Grainger
GWW
|
+$20.9M |
| 2 |
Automatic Data Processing
ADP
|
+$15.2M |
| 3 |
Comcast
CMCSA
|
+$7.22M |
| 4 |
Autodesk
ADSK
|
+$6.78M |
| 5 |
Procter & Gamble
PG
|
+$5.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.29% |
| 2 | Financials | 17.68% |
| 3 | Technology | 13.92% |
| 4 | Industrials | 12.8% |
| 5 | Consumer Staples | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PepsiCo
PEP
$176B
| $40.8M | 2.71% |
353,322
-8,305
| -2% | -$953K |
2013 Q2
16 quarters
|
|
2
Merck
MRK
$363B
| $37.8M | 2.51% |
618,220
+65,510
| +12% | +$3.99M |
2013 Q2
16 quarters
|
|
3
Amgen
AMGN
$231B
| $37.3M | 2.47% |
216,314
-2,845
| -1% | -$463K |
2013 Q2
16 quarters
|
|
|
4
Autodesk
ADSK
$48.2B
| $35.8M | 2.37% |
354,844
-68,555
| -16% | -$6.78M |
2013 Q2
16 quarters
|
|
5
Medtronic
MDT
$119B
| $34.9M | 2.31% |
393,314
-17,880
| -4% | -$1.51M |
2013 Q2
16 quarters
|
|
|
6
Visa
V
$737B
| $34.1M | 2.26% |
363,249
+71,951
| +25% | +$6.68M |
2013 Q2
16 quarters
|
|
|
VAR
7
DELISTED
Varian Medical Systems, Inc.
VAR
| $33.4M | 2.22% |
324,115
+40,705
| +14% | +$3.92M |
2016 Q2
4 quarters
|
|
8
Walt Disney
DIS
$187B
| $32.4M | 2.15% |
305,379
-28,970
| -9% | -$3.17M |
2013 Q2
16 quarters
|
|
9
Apple
AAPL
$5T
| $32M | 2.12% |
889,472
-75,900
| -8% | -$2.81M |
2013 Q2
16 quarters
|
|
10
GE Aerospace
GE
$317B
| $30.2M | 2.01% |
233,652
-1,436
| -0.6% | -$197K |
2013 Q2
16 quarters
|
|
|
11
Nike
NKE
$51.8B
| $29.5M | 1.95% |
499,589
+105,025
| +27% | +$5.67M |
2013 Q2
16 quarters
|
|
12
Caterpillar
CAT
$344B
| $29.3M | 1.94% |
272,703
+45,190
| +20% | +$4.59M |
2013 Q2
16 quarters
|
|
13
CME Group
CME
$103B
| $27.7M | 1.84% |
221,425
+1,780
| +0.8% | +$213K |
2013 Q2
16 quarters
|
|
14
Alphabet (Google) Class A
GOOGL
$4.25T
| $27.7M | 1.84% |
596,500
-59,000
| -9% | -$2.76M |
2015 Q4
6 quarters
|
|
15
Johnson Controls International
JCI
$91.4B
| $27.4M | 1.82% |
632,469
+107,842
| +21% | +$4.51M |
2015 Q1
9 quarters
|
|
16
Gilead Sciences
GILD
$191B
| $26.9M | 1.79% |
380,473
-5,705
| -1% | -$380K |
2013 Q2
16 quarters
|
|
|
17
SLB Ltd
SLB
$71.5B
| $26.1M | 1.73% |
395,860
+144,620
| +58% | +$10.4M |
2013 Q2
16 quarters
|
|
18
McCormick & Company Non-Voting
MKC
$12B
| $25.5M | 1.69% |
523,930
+3,940
| +0.8% | +$199K |
2014 Q1
13 quarters
|
|
|
19
Procter & Gamble
PG
$362B
| $25M | 1.66% |
286,761
-62,770
| -18% | -$5.53M |
2013 Q2
16 quarters
|
|
20
Microsoft
MSFT
$3.97T
| $23.2M | 1.54% |
336,332
-24,300
| -7% | -$1.67M |
2013 Q2
16 quarters
|
|
21
Qualcomm
QCOM
$184B
| $21.3M | 1.41% |
386,325
-6,950
| -2% | -$388K |
2013 Q2
16 quarters
|
|
22
ExxonMobil
XOM
$729B
| $19.7M | 1.3% |
243,709
-5,200
| -2% | -$425K |
2013 Q2
16 quarters
|
|
23
Alphabet (Google) Class C
GOOG
$4.2T
| $19.1M | 1.26% |
419,780
+4,400
| +1% | +$201K |
2013 Q2
16 quarters
|
|
|
24
JPMorgan Chase
JPM
$886B
| $18.8M | 1.25% |
205,463
+92,700
| +82% | +$8M |
2013 Q2
16 quarters
|
|
25
Johnson & Johnson
JNJ
$610B
| $18M | 1.19% |
136,124
+9,375
| +7% | +$1.2M |
2013 Q2
16 quarters
|
|
Similar funds
MF
AIM
QCMA
SC
BIM
GP
GAM
SCM
Oakbrook Investments's Q2 2017 Portfolio in Review
As of Q2 2017, Oakbrook Investments held 609 positions worth $1.51B, down 1.6% from $1.53B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Oakbrook Investments withdrew a net $65.2M in Q2 2017, closing 88 positions and reducing 312 holdings. Its most notable exit was W.W. Grainger, an estimated $20.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Oakbrook Investments opened a new position in MetLife worth $4.05M.
- Oakbrook Investments's largest Q2 2017 buy was MetLife: 82,804 shares worth $4.05M.
- Oakbrook Investments added most to SLB Ltd in Q2 2017, an estimated $10.4M increase.
- Oakbrook Investments's biggest Q2 2017 reduction was Automatic Data Processing, cutting an estimated $15.2M.
- Oakbrook Investments fully exited W.W. Grainger in Q2 2017, selling an estimated $20.9M.
- Oakbrook Investments's ten largest holdings make up 23% of its $1.51B portfolio in Q2 2017.
- Oakbrook Investments opened 85 new positions and closed 88 in Q2 2017.
- Oakbrook Investments's portfolio value fell 1.6% quarter-over-quarter to $1.51B.
Based on Oakbrook Investments's 13F filing for Q2 2017, filed 20 Jul 2017.